Evidence map›Paper›PMID 41020135›Full record

ArticleNature machine intelligence2024

Reusability report: Leveraging supervised learning to uncover phenotype-relevant biology from single-cell RNA sequencing data.

Yingying Cao, Tian-Gen Chang, Sahil Sahni, Eytan Ruppin

Abstract read
In one paragraph

Article in Nature machine intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yingying CaoCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Tian-Gen ChangCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-1485-1992
Sahil SahniCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0009-0006-4678-3903
Eytan RuppinCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-7862-3940

Funding

Computational studies of cancer immunotherapyZIABC011803 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RUPPIN, EYTAN · 2018 to 2025
$10.7M
Intramural NIH HHS ZIA BC011803
6 · The paper itself

Abstract

Recent advances in single-cell transcriptome sequencing and computational analysis methods have improved our understanding of cellular heterogeneity. However, associating different cell subsets with phenotypes remains challenging. Recently, Ren et al. introduced PENCIL, a supervised learning framework incorporating gene selection to discern phenotype-relevant cells. To assess PENCIL's reproducibility and transferability, we conducted a comprehensive evaluation across 12 single-cell RNA sequencing datasets representing four distinct phenotypes. We identified a few caveats with the original version of PENCIL, such as sensitivity to input perturbation, the correction of which contributed to PENCIL's enhanced reproducibility. We highlight that boosting PENCIL's cell subsets identification with gene set variation analysis creates a cytotoxic T cell immunotherapy response signature (CyTIR) predictive of immune checkpoint blockade response in skin cancer across multiple datasets, with an area under curve >0.75 and accuracy >0.71. Overall, our assessments enhance PENCIL's reproducibility and utility, further extending its potential for identifying phenotype-relevant cell subsets in diverse biomedical applications.

Identifiers

PMID41020135
PMCPMC12467577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.